Improving Treatment Outcomes: Advancing Adjuvant Therapy for Early ER+ Breast CancerDr Erica Mayer is the director of clinical research and institute physician at the Breast Oncology Centre, Dana-Faber Cancer Institute, and associate professor of medicine at Harvard Medical School in Boston, United States.Dr Mayer's research focuses on the role of novel therapies in the treatment of breast cancer and we spoke with her about improving efficacy in the adjuvant treatment of early ER+ breast cancer.Tune in for a deep dive into this important research.⁠⁠⁠⁠⁠⁠⁠⁠Donate to Support Life-Saving Research⁠⁠⁠⁠⁠⁠⁠⁠Like this episode? ⁠⁠⁠⁠⁠⁠⁠⁠Find more Breast Cancer Trials Podcast Episodes here⁠⁠⁠⁠⁠⁠⁠⁠Follow Breast Cancer Trials on Social Media: Instagram:⁠ ⁠⁠⁠⁠⁠⁠⁠@breastcancertrials⁠⁠⁠⁠⁠⁠⁠⁠ Facebook:⁠ ⁠⁠⁠⁠⁠⁠⁠Breast Cancer Trials⁠⁠⁠⁠⁠⁠⁠⁠ LinkedIn: ⁠⁠⁠⁠⁠⁠⁠⁠Breast Cancer Trials⁠⁠⁠⁠⁠⁠⁠⁠ X: ⁠⁠⁠⁠⁠⁠⁠⁠@BCTrialsANZ⁠⁠⁠⁠⁠⁠⁠⁠Guest: Dr Erica MayerThank you for listening! If you found this episode valuable, please share it with your loved ones and help spread awareness about the importance of breast cancer trials research. Find out more: ⁠⁠⁠Breast Cancer Trials⁠⁠⁠

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related